NCT03982446View on ClinicalTrials.gov

Germline Mutations in Pancreatic Adenocarcinoma

CompletedOBSERVATIONAL
Enrollment

549

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

November 1, 2019

Study Completion Date

January 3, 2020

Conditions
Germline Mutation AbnormalityPancreatic CancerPredisposition, GeneticHereditary Cancer
Interventions
GENETIC

Mutations

Trial Locations (1)

Unknown

Hellenic Oncology Cooperative Group, Athens

All Listed Sponsors
lead

Hellenic Cooperative Oncology Group

OTHER

NCT03982446 - Germline Mutations in Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter